Skip to main content

Cardiff Oncology, Inc.

CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213037

In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Cardiff Oncology, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CRDF: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders7790+13
Shares8.60M13.1M+4.49M (+52.2%)
Value$45.8M$29.1M−$16.8M (−36.6%)

New holders (29)

Institutions that held Cardiff Oncology, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CRDF in Q2 2024
InstitutionSharesValue% of portfolio
UBS Oconnor LLC150,000$333.0K0.01%
Avestar Capital, LLC140,469$311.8K0.03%
Bank of New York Mellon Corp115,304$256.0K0.00%
Jump Financial, LLC85,838$190.6K0.00%
XTX Topco Ltd83,437$185.2K0.02%
Citadel Advisors LLC55,796$123.9K0.00%
Nuveen Asset Management, LLC53,116$117.9K0.00%
Thoroughbred Financial Services, LLC52,375$116.0K0.01%
Rhumbline Advisers45,993$102.1K0.00%
New York State Common Retirement Fund43,000$95.5K0.00%
Graham Capital Management, L.P.41,922$93.1K0.00%
Cetera Investment Advisers40,500$89.9K0.00%
Alpine Global Management, LLC37,924$84.2K0.01%
Gsa Capital Partners LLP35,037$78.0K0.01%
Invst, LLC36,000$73.8K0.01%
Paloma Partners Management Co29,090$64.6K0.01%
Corebridge Financial, Inc.21,075$47.0K0.00%
Invesco Ltd.18,180$40.4K0.00%
Ground Swell Capital, LLC17,098$38.0K0.04%
Occudo Quantitative Strategies LP14,566$32.3K0.01%
Barclays PLC13,547$30.1K0.00%
Point72 (DIFC) Ltd12,284$27.3K0.00%
Alliancebernstein L.P.10,380$23.0K0.00%
Legal & General Group Plc3,824$8.55K0.00%
Ameritas Investment Partners, Inc.3,838$8.52K0.00%
California State Teachers Retirement System2,839$6.30K0.00%
Amalgamated Bank1,355$3.00K0.00%
Clearstead Advisors, LLC700$1.55K0.00%
FMR LLC300$6660.00%

Sold out (16)

Institutions that held Cardiff Oncology, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.